Latest Investigational Device Exemption Stories
ATLANTA, April 28, 2015 /PRNewswire/ -- CryoLife, Inc.
METAIRIE, La., April 15, 2015 /PRNewswire/ -- Moirai Orthopaedics, L.L.C., an orthopaedic implant development company based in Metairie, Louisiana, is pleased to announce it has received approval
The 50cc heart is the smaller version of the 70cc SynCardia Heart, which is FDA, Health Canada and CE mark approved.
IDE approval follows recent CE Mark approval, with initial EU/Asia Pacific commercialization to begin in 2015 MOUNTAIN VIEW, Calif., March 18, 2015 /PRNewswire/ -- Simplify Medical,
ALISO VIEJO, Calif., Feb. 12, 2015 /PRNewswire/ -- Sequent Medical announced today that the U.S.
MONMOUTH JUNCTION, N.J., Dec.
Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Gastrointestinal Resections PITTSBURGH, Dec.
Based on the results of the trial's pre-specified interim analysis all control patients in the EF-14 phase III trial will be offered the opportunity to cross over to receive Tumor Treating Fields
ALISO VIEJO, Calif., Aug. 28, 2014 /PRNewswire/ -- Sequent Medical, Inc.
SAN JOSE, Calif., June 10, 2014 /PRNewswire/ -- Pulsar Vascular, the innovator and developer of the PulseRider®, a minimally invasive, aneurysm neck reconstruction device,
- The abrogation of a law by a higher authority; annulment.